We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+0.61%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
–
AUM
$14.7B
AUM Growth
+$1.55B
Cap. Flow
-$42.4M
Cap. Flow %
-0.29%
Top 10 Hldgs %
33.58%
Holding
2,110
New
660
Increased
423
Reduced
368
Closed
648

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$231M
2
COP icon
ConocoPhillips
COP
+$114M
3
AAPL icon
Apple
AAPL
+$80.8M
4
BDX icon
Becton Dickinson
BDX
+$68.3M
5
SHW icon
Sherwin-Williams
SHW
+$62.8M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$351M
2
META icon
Meta Platforms (Facebook)
META
+$242M
3
GPN icon
Global Payments
GPN
+$202M
4
FCX icon
Freeport-McMoran
FCX
+$70.4M
5
PPL
PPL Corp
PPL
+$61.6M

Sector Composition

Rank Sector Weight
1 Healthcare 10.2%
2 Technology 10.13%
3 Utilities 6.69%
4 Consumer Discretionary 6.52%
5 Industrials 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XRAY icon
2051
Dentsply Sirona
XRAY
$2.18B
– –
-11,586
Closed -$385K
XSD icon
2052
State Street SPDR S&P Semiconductor ETF
XSD
$2.69B
– –
-55
Closed -$13K
ZBH icon
2053
Zimmer Biomet
ZBH
$19.3B
– –
-98,802
Closed -$13M
ZETA icon
2054
Zeta Global
ZETA
$7.3B
– –
-139,583
Closed -$1.53M
GTM
2055
ZoomInfo Technologies
GTM
$1.16B
– –
-149,506
Closed -$2.4M
ZION icon
2056
Zions Bancorporation
ZION
$9.95B
– –
-98,949
Closed -$4.29M
ZM icon
2057
Zoom
ZM
$31.5B
– –
-91,899
Closed -$6.01M
ZTO icon
2058
ZTO Express
ZTO
$16.2B
– –
-131,877
Closed -$2.76M
ZTS icon
2059
Zoetis
ZTS
$32.1B
– –
-68,532
Closed -$11.6M
FBLG icon
2060
FibroBiologics
FBLG
$9.59M
– –
-1,280
Closed -$277K
AHR icon
2061
American Healthcare REIT
AHR
$12.2B
– –
-352,996
Closed -$5.21M
MTUS icon
2062
Metallus
MTUS
$812M
– –
-54,799
Closed -$1.22M
SMXT icon
2063
Solarmax Technology
SMXT
$17.3M
– –
-1,326
Closed -$146K
DJTWW
2064
Trump Media & Technology Group Warrants
DJTWW
$900M
– –
-23,266
Closed -$637K
SOLV icon
2065
Solventum
SOLV
$15.2B
– –
-16,340
Closed -$1.14M
CNR
2066
Core Natural Resources Inc
CNR
$4.72B
– –
-2,742
Closed -$230K
BWIN
2067
Baldwin Insurance Group
BWIN
$3.09B
– –
-29,892
Closed -$865K
NBIS
2068
Nebius Group N.V.
NBIS
$59.6B
$0 ﹤0.01%
51,308
– –
GAP
2069
The Gap Inc
GAP
$7.13B
– –
-34,420
Closed -$948K
NPKI
2070
NPK International
NPKI
$1.16B
– –
-21,032
Closed -$152K
SGI
2071
Somnigroup International
SGI
$13.6B
– –
-32,355
Closed -$1.84M
QVCGB
2072
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
– –
0
– –
QVCGA
2073
DELISTED
QVC Group Inc Series A
QVCGA
– –
-7,606
Closed -$468K
FFAI
2074
Faraday Future Intelligent Electric
FFAI
$12.3M
– –
-11
Closed -$6K
NAGE
2075
Niagen Bioscience
NAGE
$254M
– –
-20,930
Closed -$73K
81 82
83
84 85

Similar funds

FGP
Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $15.3B AUM 18.32% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return

Michael Gelband's Q2 2024 Portfolio in Review

As of Q2 2024, Michael Gelband held 2,110 positions worth $14.7B, up 12% from $13.1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Michael Gelband's Q2 2024 filing shows 660 new, 423 increased, 368 reduced and 648 closed positions. Its largest new stake was Coca-Cola: 936,563 shares worth $59.6M. The largest sale was NVIDIA, an estimated $351M.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, up from 6.9% a quarter earlier, followed by Technology and Utilities.

  • Michael Gelband's largest Q2 2024 buy was Coca-Cola: 936,563 shares worth $59.6M.
  • Michael Gelband added most to Amazon in Q2 2024, an estimated $231M increase.
  • Michael Gelband's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $351M.
  • Michael Gelband fully exited Global Payments in Q2 2024, selling an estimated $202M.
  • Michael Gelband's ten largest holdings make up 34% of its $14.7B portfolio in Q2 2024.
  • Michael Gelband opened 660 new positions and closed 648 in Q2 2024.
  • Michael Gelband's portfolio value rose 12% quarter-over-quarter to $14.7B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.